Elevated levels of inflammatory markers (e.g., C-reactive protein [CRP], interleukin (IL)-6, and tumor necrosis factor-α (TNF-α)) are commonly observed [11,12,20,21,22], along with an increased erythrocyte sedimentation rate (ESR), in CKD patients, as reported in several studies [23,24,25,26,27,28,29]. This evidence concerns the gene CRP and chronic kidney disease.